相似文献
1
Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity.
J Clin Microbiol. 2007 Aug;45(8):2686-90. doi: 10.1128/JCM.00917-07. Epub 2007 Jun 20.
2
A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates.
Clin Microbiol Infect. 2008 Dec;14(12):1146-51. doi: 10.1111/j.1469-0691.2008.02099.x.
3
Rep-PCR and RAPD-PCR fingerprinting of Aspergillus terreus.
Med Mycol. 2013 Nov;51(8):876-9. doi: 10.3109/13693786.2013.793458. Epub 2013 Jun 13.
4
Molecular typing of Aspergillus terreus isolates by random amplification of polymorphic DNA.
J Hosp Infect. 2000 Apr;44(4):273-80. doi: 10.1053/jhin.1999.0707.
5
Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study.
J Hosp Infect. 2011 Jul;78(3):226-30. doi: 10.1016/j.jhin.2011.01.020. Epub 2011 Mar 25.
6
Aspergillus terreus complex.
Med Mycol. 2009;47 Suppl 1:S42-6. doi: 10.1080/13693780802562092. Epub 2009 Mar 17.
7
Molecular typing of Aspergillus terreus by random amplification of polymorphic DNA.
Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):838-41. doi: 10.1007/s100960050415.
8
Comparison of restriction fragment length polymorphism, microsatellite length polymorphism, and random amplification of polymorphic DNA analyses for fingerprinting Aspergillus fumigatus isolates.
J Clin Microbiol. 2001 Jul;39(7):2683-6. doi: 10.1128/JCM.39.7.2683-2686.2001.
9
Evolutionary relationships among Aspergillus terreus isolates and their relatives.
Antonie Van Leeuwenhoek. 2005 Aug;88(2):141-50. doi: 10.1007/s10482-005-3870-6.
10
Diversity, molecular phylogeny and fingerprint profiles of airborne Aspergillus species using random amplified polymorphic DNA.
World J Microbiol Biotechnol. 2016 Jun;32(6):96. doi: 10.1007/s11274-016-2052-1. Epub 2016 Apr 27.
引用本文的文献
1
Exploring Factors Driving the Uneven Distribution of in an Austrian Hotspot Region.
Microorganisms. 2025 May 27;13(6):1218. doi: 10.3390/microorganisms13061218.
2
Drug-Resistant spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe.
Pathogens. 2023 Oct 31;12(11):1305. doi: 10.3390/pathogens12111305.
3
Antibody Serosurveillance in Tyrol: A Population-Based, Cross-Sectional Study of a Healthy Population.
J Fungi (Basel). 2023 Oct 12;9(10):1008. doi: 10.3390/jof9101008.
4
The Novel Monoclonal IgG-Antibody AB90-E8 as a Diagnostic Tool to Rapidly Distinguish from Other Human Pathogenic Species.
J Fungi (Basel). 2023 May 28;9(6):622. doi: 10.3390/jof9060622.
5
Molecular Diversity of Aspergilli in Two Iranian Hospitals.
Mycopathologia. 2021 Aug;186(4):519-533. doi: 10.1007/s11046-021-00563-z. Epub 2021 May 30.
6
and aspergillosis: From basics to clinics.
Stud Mycol. 2021 May 10;100:100115. doi: 10.1016/j.simyco.2021.100115. eCollection 2021 Sep.
7
The Environmental Spread of in Tyrol, Austria.
Microorganisms. 2021 Mar 5;9(3):539. doi: 10.3390/microorganisms9030539.
8
Resistance mechanism and proteins in species against antifungal agents.
Mycology. 2019 Feb 6;10(3):151-165. doi: 10.1080/21501203.2019.1574927. eCollection 2019.
9
Cryptic species of section display essential physiological features to cause infection and are similar in their virulence potential in .
Virulence. 2019 Dec;10(1):542-554. doi: 10.1080/21505594.2019.1614382.
10
Treatment of Infections Due to Species Complex.
J Fungi (Basel). 2018 Jul 9;4(3):83. doi: 10.3390/jof4030083.
本文引用的文献
1
Low genetic variation and no detectable population structure in aspergillus fumigatus compared to closely related Neosartorya species.
Eukaryot Cell. 2006 Apr;5(4):650-7. doi: 10.1128/EC.5.4.650-657.2006.
2
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Br J Haematol. 2005 Oct;131(2):201-7. doi: 10.1111/j.1365-2141.2005.05763.x.
3
Evolutionary relationships among Aspergillus terreus isolates and their relatives.
Antonie Van Leeuwenhoek. 2005 Aug;88(2):141-50. doi: 10.1007/s10482-005-3870-6.
4
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Diagn Microbiol Infect Dis. 2005 May;52(1):15-20. doi: 10.1016/j.diagmicrobio.2005.01.001.
5
Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus.
J Hosp Infect. 2005 May;60(1):61-8. doi: 10.1016/j.jhin.2004.10.009.
6
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
Cancer. 2004 Oct 1;101(7):1594-600. doi: 10.1002/cncr.20554.
7
Epidemiology of Aspergillus terreus at a university hospital.
J Clin Microbiol. 2003 Dec;41(12):5525-9. doi: 10.1128/JCM.41.12.5525-5529.2003.
8
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
J Infect Dis. 2003 Jul 15;188(2):305-19. doi: 10.1086/377210. Epub 2003 Jul 9.
9
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191.
10
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clin Infect Dis. 2002 Jan 1;34(1):7-14. doi: 10.1086/323335. Epub 2001 Nov 26.
Zotero 插件